IMC Chicago
GMAB icon

IMC Chicago’s Genmab GMAB Stock Holding History

IMC Chicago’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$818K Buy
30,500
+20,200
+196% +$605K ﹤0.01% 3478
2025
Q4 		$317K Buy
+10,300
New +$321K ﹤0.01% 3770

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

IMC Chicago's GMAB Position: Q1 2026 in Review

IMC Chicago sold out of Genmab (GMAB) in Q1 2026, closing a stake of 27,537 shares — an estimated $825K sold.

IMC Chicago first reported a position in GMAB in Q3 2025 and held it in 2 quarters. The position peaked at $848K in Q4 2025. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • IMC Chicago reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 27,537 Genmab shares in Q1 2026, an estimated $825K.
  • IMC Chicago first reported a position in Genmab in Q3 2025 and held it in 2 quarters.
  • IMC Chicago's Genmab position peaked at $848K in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.